Magic mushroom therapy aims to ease cancer Patients' mental anguish
NCT ID NCT05220046
First seen Jan 07, 2026 · Last updated May 14, 2026 · Updated 14 times
Summary
This early-stage study tests whether a carefully guided psilocybin (magic mushroom) session can help reduce depression and anxiety in people with advanced, incurable gastrointestinal cancers. The study enrolls 24 adults aged 19-85 who live near Omaha, NE, and have a family member willing to participate. Researchers are primarily checking if the approach is practical and acceptable, while also measuring changes in mood and distress.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOLOGICAL DISTRESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.